文献速递甲状腺与浅表头颈US

BRAFV600E突变与美国放射学会甲状腺影像报告和数据系统在孤立性甲状腺乳头状癌中的关联

Association Between BRAFV600E Mutation and the American College of Radiology Thyroid Imaging, Reporting and Data System in Solitary Papillary Thyroid Carcinoma.
PubMed 文献 · Acad Radiol · 2018-06-23

这项回顾性研究纳入397例病理证实的孤立性甲状腺乳头状癌患者,采用实时荧光PCR检测术后标本BRAFV600E突变,分析其与ACR TI-RADS及临床病理特征的关联。结果显示BRAFV600E突变率为81.4%(323/397),分叶或不规则边缘独立关联BRAFV600E突变,ACR TI-RADS评分越高突变风险越高,尤其在甲状腺微小乳头状癌中,而桥本甲状腺炎与BRAFV600E突变呈显著负关联。

要点

  • 孤立性PTC中分叶或不规则边缘独立关联BRAFV600E突变。
  • ACR TI-RADS评分越高,BRAFV600E突变风险越高,微小癌中尤明显。
  • 桥本甲状腺炎与BRAFV600E突变呈显著负关联。

核心结论

  • 甲状腺结节分叶或不规则边缘独立关联PTC患者BRAFV600E突变,ACR TI-RADS评分较高是BRAFV600E突变的独立危险因素,评分与突变风险正相关,尤其在微小乳头状癌中。

研究设计与样本

  • 回顾性研究,纳入397例病理证实的孤立性甲状腺乳头状癌患者,术后标本采用实时荧光聚合酶链反应检测BRAFV600E突变,分析其与ACR TI-RADS及临床病理特征的关联。

关键影像表现/征象

  • 分叶或不规则边缘在总孤立性PTC中独立关联BRAFV600E突变。
  • 桥本甲状腺炎与BRAFV600E突变呈显著负关联。

诊断标准与关键数值

  • 孤立性PTC中BRAFV600E突变发生率为81.4%(323/397)。
  • 总孤立性PTC及甲状腺微小乳头状癌中,BRAFV600E突变与ACR TI-RADS评分相关,评分与突变风险正相关。
  • PTC>10 mm中BRAFV600E突变与ACR TI-RADS评分无显著关系。

临床应用与阅片要点

  • 作者认为上述发现可能有助于BRAFV600E突变PTC患者的术前识别和医疗管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The purpose of this study was to evaluate the associations between BRAFV600E mutation, the American College of Radiology (ACR) thyroid imaging, reporting and data system (TI-RADS) on ultrasound and clinicopathological characteristics in patients with a solitary papillary thyroid carcinoma (PTC).

MATERIALS AND METHODS: This retrospective study included 397 patients with a solitary PTC, proved pathologically. BRAFV600E mutation status was detected in postoperative samples by real-time fluorescent polymerase chain reaction. Associations of BRAFV600E mutation with the ACR TI-RADS and clinicopathological characteristics were analyzed.

RESULTS: In this study, the incidence of BRAFV600E mutation was 81.4% (323/397) in patients with a solitary PTC. Univariate analyses showed that BRAFV600E mutation was significantly associated with margin, higher ACR TI-RADS point scores, and Hashimoto's thyroiditis. In multivariate analyses, lobulated or irregular margin was independently associated with BRAFV600E mutation in total solitary PTC. Furthermore, both in total solitary PTC and papillary thyroid microcarcinoma, BRAFV600E mutation was associated with ACR TI-RADS point scores, which was positively correlated with the risk of BRAFV600E mutation. There was no significant relationship between BRAFV600E mutation and ACR TI-RADS point scores in PTC >10 mm. In addition, Hashimoto's thyroiditis had a significant negative association with BRAFV600E mutation.

CONCLUSION: A lobulated or irregular margin of the thyroid nodule is independently associated with BRAFV600E mutation in patients with PTC. In addition, higher ACR TI-RADS point scores is an independent risk factor for BRAFV600E mutation, and ACR TI-RADS point scores is positively associated with the risk of BRAFV600E mutation in solitary PTC, especially in papillary thyroid microcarcinoma. Our findings may be helpful for preoperative identification and medical management of PTC patients with BRAFV600E mutation.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Shangguan R, Hu YP, Huang J, et al. Association Between BRAFV600E Mutation and the American College of Radiology Thyroid Imaging, Reporting and Data System in Solitary Papillary Thyroid Carcinoma. Acad Radiol. 2018. PMID: 29941398. doi:10.1016/j.acra.2018.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。